Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 96,000 shares, an increase of 115.7% from the October 15th total of 44,500 shares. Based on an average daily volume of 35,155 shares, the short-interest ratio is presently 2.7 days.
Voyageur Pharmaceuticals Price Performance
Shares of VYYRF opened at $0.09 on Monday. Voyageur Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $1.03. The stock’s 50 day moving average is $0.10 and its two-hundred day moving average is $0.10.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd. is a Canadian specialty pharmaceutical company focused on the development and manufacture of barium sulfate products used as contrast agents in diagnostic medical imaging. Barium sulfate is administered orally or rectally to help improve the visibility of the gastrointestinal tract during X-ray and computed tomography examinations. The company’s activities include the production of pharmaceutical-grade barium sulfate and the development of finished contrast-media formulations for healthcare and diagnostic-imaging markets.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
